| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |